XTX Topco’s RAPT Therapeutics RAPT Stock Holding History

XTX Topco’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-18,195	Closed	-$616K	–	4279
2025 Q4	$616K	Buy	+18,195	New	+$565K	0.02%	1416
2024 Q3	–	Sell	-4,435	Closed	-$108K	–	2504
2024 Q2	$108K	Buy	+4,435	New	+$205K	0.01%	1401

XTX Topco's RAPT Position: Q1 2026 in Review

XTX Topco sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 18,195 shares — an estimated $616K sold.

XTX Topco first reported a position in RAPT in Q2 2024 and held it in 2 quarters. The position peaked at $616K in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

XTX Topco reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
XTX Topco sold 18,195 RAPT Therapeutics shares in Q1 2026, an estimated $616K.
XTX Topco first reported a position in RAPT Therapeutics in Q2 2024 and held it in 2 quarters.
XTX Topco's RAPT Therapeutics position peaked at $616K in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.